Lgi1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| LGI1 (Epitempin) Protein | |
|---|---|
| Protein Name | Leucine-rich glioma inactivated 1 |
| Alternative Names | Epitempin, EPTP, ADAM22 ligand |
| Gene | LGI1 |
| UniProt ID | O75771 |
| PDB ID | 2M0M, 2MVH, 3LKK |
| Molecular Weight | 63 kDa (557 amino acids) |
| Subcellular Localization | Secreted, synaptic membrane |
| Protein Family | LGI family |
| Tissue Specificity | Brain (neurons), testis |
LGI1 (Leucine-Rich Glioma Inactivated 1) is a secreted neuronal protein that plays critical roles in synaptic transmission, AMPA receptor trafficking, and neurological disease pathogenesis. Originally identified as a tumor suppressor gene in gliomas, LGI1 is now recognized as a key regulator of synaptic function and is implicated in epilepsy, Alzheimer's disease, and other neurological disorders.
LGI1 is unique among the LGI family proteins as it is the only member known to be secreted and function extracellularly. It acts as a ligand for ADAM22 and ADAM23 receptors, linking presynaptic and postsynaptic compartments.
LGI1 contains several distinct domains:
Signal Peptide (1-20 aa): N-terminal secretion signal that targets the protein to the secretory pathway
Leucine-Rich Repeats (LRR) (30-220 aa): Seven LRR units that mediate protein-protein interactions with ADAM receptors
Epitempin (EPTP) Domain (320-557 aa): C-terminal domain involved in protein oligomerization and receptor binding
The LRR domain binds to the disintegrin domains of ADAM22/ADAM23, while the EPTP domain mediates LGI1 homodimerization and interaction with other proteins.
LGI1 is essential for normal synaptic function:
LGI1 functions as a synaptic organizer:
LGI1 undergoes alternative splicing, generating multiple isoforms with potentially distinct functions. The major brain isoform contains all functional domains.
LGI1-related therapies are being explored:
The study of Lgi1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.